Stanford University
Showing 101-110 of 677 Results
-
Christopher Cheung, MD
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Christopher Cheung is a board-certified, fellowship-trained pain medicine specialist and anesthesiologist at the Stanford Health Care Pain Management Center. He is also a clinical assistant professor in the Department of Anesthesiology, Perioperative and Pain Medicine at Stanford University School of Medicine.
Dr. Cheung cares for patients with a wide range of acute and chronic pain conditions, including spine-related pain, neuropathic pain, and postsurgical pain. He specializes in using medications and interventional procedures such as nerve blocks, spine injections, radiofrequency ablation, and neuromodulation to improve function and quality of life. Working closely with patients from diagnosis through treatment, Dr. Cheung focuses on providing personalized, high-quality care.
Dr. Cheung’s research has explored innovative neuromodulation techniques and evidence-based strategies for pain management after surgery. His work has been presented at national conferences and published in peer-reviewed journals. -
Lawrence Chu, MD, MS
Professor of Anesthesiology, Perioperative and Pain Medicine (MSD)
Current Research and Scholarly InterestsI have two lines of research, one involving educational informatics and use of technology in postgraduate medical education and another involving NIH-funded work in patient-oriented clinical research regarding opioid use and physiologic responses associated with acute and chronic exposure in humans.
For a full description of my educational informatics work, please see my website aim.stanford.edu.
My clinical research focuses on the study opiate-induced hyperalgesia in patients suffering from chronic pain.
I am currently conducting an NIH-funded five year double-blinded randomized controlled clinical study (NIGMS award 1K23GM071400-01) that prospectively examines the following hypotheses: 1) pain patients on chronic opioid therapy develop dose-dependent tolerance and/or hyperalgesia to these medications over time, 2) opiate-induced tolerance and hyperalgesia develop differently with respect to various types of pain, 3) opioid-induced hyperalgesia occurs independently of withdrawal phenomena, and 4) opiate-induced tolerance and hyperalgesia develop differently based on gender and/or ethnicity.
The study is the first quantitative and prospective examination of tolerance and hyperalgesia in pain patients and may have important implications for the rational use of opioids in the treatment of chronic pain.
